Shikonin combined with curcumin synergistically induces apoptosis of glioma cells by inhibiting the PI3K/Akt/NF-κB signaling pathway
Glioblastoma (GBM) is a highly aggressive, recurrent and drug-resistant malignancy of the central nervous system, with a poor prognosis and a median survival rate of <18 months, highlighting the need for the identification of novel therapeutic approaches. The natural products shikonin and curcumin have been reported to...